Physician profile
Michael S Hager
NPI 1295387652
$1,661.84
in general payments reported to CMS, 2019-2025
19 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.15 · 2022: $56.54 · 2023: $359 · 2024: $743 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,533.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $336.61 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $279.58 | 2023-2025 | Aveir, Gallant, Jot Dx |
| Abiomed | $260.26 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $176.24 | 2021-2025 | |
| Shockwave Medical, INC | $111.51 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heron Therapeutics, INC. | $109.97 | 2025 | Zynrelef, Aponvie |
| Cardiva Medical, INC. | $95.64 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $69.19 | 2021-2023 | Endurant Iis |
| Actelion Pharmaceuticals US, INC. | $26.52 | 2023 | Opsumit, Uptravi |
| Biosense Webster, INC. | $24.92 | 2024 | Qdot Micro Catheter |
| Ethicon US, LLC | $23.67 | 2024 | Dermabond, Stratafix |
| Novo Nordisk INC | $23.56 | 2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $21.63 | 2022 | |
| Teleflex LLC | $19.54 | 2022 | |
| Revance Therapeutics, INC. | $18.94 | 2024 | Daxxify |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $17.84 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Astrazeneca Pharmaceuticals LP | $17.65 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.37 | 2022 | |
| Chiesi USA, INC. | $13.20 | 2024 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.